Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05031663 · ClinicalTrials.gov registry record · NA

Effect of Almonds on Immune Strength and Response to Flu Vaccination in Overweight Older Men and Postmenopausal Women: A Randomized Controlled Study

A NA study of Inflammation and Immune Response, sponsored by Loma Linda University.

Completed
Registry status
NA
Development phase
61
Enrollment target
1
Study location

NCT05031663 is a NA study of Inflammation and Immune Response that has completed, run by Loma Linda University. The registered enrollment target is 61 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05031663, a NA study of Inflammation and Immune Response, has completed, sponsored by Loma Linda University.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

This research study will test the effects of almonds on immune functions and immune response to influenza vaccine in overweight middle-aged men and postmenopausal women

Interventions

  • DIETARY_SUPPLEMENT Almond group
  • DIETARY_SUPPLEMENT Control Group

Study Locations (1)

California

  • Loma Linda University School of Public Health - Loma Linda

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2021-08-12
Est. Completion 2023-05-10
Phase NA

Sponsor

Loma Linda University

237 total trials

What the Registry Record Tells You About NCT05031663

The ClinicalTrials.gov registry entry for NCT05031663 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (79% lower). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Almond group is the first listed.

NCT05031663 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05031663 about?

NCT05031663 is a clinical study titled "Effect of Almonds on Immune Strength and Response to Flu Vaccination in Overweight Older Men and Postmenopausal Women: A Randomized Controlled Study". This research study will test the effects of almonds on immune functions and immune response to influenza vaccine in overweight middle-aged men and postmenopausal women

What is the current status of trial NCT05031663?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2021-08-12. Estimated completion is 2023-05-10.

What conditions does trial NCT05031663 study?

This clinical trial studies the following conditions: Inflammation, Immune Response.

What interventions are being tested in trial NCT05031663?

The interventions under investigation include: Almond group (DIETARY_SUPPLEMENT), Control Group (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05031663?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05031663 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.